Abstract:Patients, methods, and results The patients comprised 60 consecutive women with breast cancer aged from 24 to 66 years (mean 43-3). Chemotherapy combinations were based on doxorubicin for locally advanced cancer and cyclophosphamide for adjuvant treatment of local disease. Before treatment data were collected on the women's knowledge and expectations of chemotherapy. During treatment their experiences of side effects were reported. These data were collected mainly by interview. Reflections on chemotherapy, including views on information and support provided, were reported at follow up three weeks after treatment by postal questionnaire, which was returned by 51 women. The women's knowledge about their forthcoming treatment was limited. Eleven had no knowledge of the drugs used and some of them did not even appreciate that chemotherapy took different forms. All women reported being warned about possible side effects, most commonly those of hair loss and sickness (table). These two problems were the ones most often expected to be the most difficult. Though hair loss was expected to be the worst side effect by 35 women, fewer (13) eventually reported it as such despite the fact that 37 women eventually had alopecia. Similarly, sickness was reported as the most difficult side effect by fewer women than had expected this (four v 11). In general the side effects actually experienced by the women were rather different and more diverse than they had expected. More side effects were experienced than they had been warned to expect; the women experienced a mean of 5-4 side effects after the first treatment and 6-7 after the last compared with the 3 7 they had been warned about. A total of36 different side effects were reported. Those most often reported were tiredness, nausea, loss of appetite, mouth soreness, pain, sickness, and sore eyes. Unforewarned side effects included weight change, hot flushes or night Side effects that women reported having been warned about in advance

Mass spectrometry in nutrition: Understanding dietary health effects at the molecular level

Changing attitudes of citizens toward mental health care

Recent advances in the application of mass spectrometry in food-related analysis

Profiling techniques in nutrition and health research

Patient Involvement in the Design of a Patient-Centered Clinical Trial to Promote Adherence to Supplemental Oxygen Therapy in COPD

Proteomics in nutrition research: principles, technologies and applications

Exploring the Utilization and Application of Mass Spectrophotometry across Various Fields within Clinical Laboratory Science

Food allergen detection by mass spectrometry: the role of systems biology

Suitability of High-Resolution Mass Spectrometry for Routine Analysis of Small Molecules in Food, Feed and Water for Safety and Authenticity Purposes: A Review

New Technologies for Nutrition Research

Mass spectrometry in food authentication and origin traceability

The pivotal role of mass spectrometry in determining the presence of chemical contaminants in food raw materials

Mass Spectrometry and Protein Analysis

The current role of high-resolution mass spectrometry in food analysis

Overview of the Applications of Tandem Mass Spectrometry (MS/MS) in Food Analysis of Nutritionally Harmful Compounds

Mass spectrometry in food proteomics: a tutorial

Intake Biomarkers for Nutrition and Health: Review and Discussion of Methodology Issues

Effects of withdrawing erythropoietin.

Metabolomics-Based Dietary Biomarkers in Nutritional Epidemiology-Current Status and Future Opportunities.

Mass spectrometry for translational proteomics: progress and clinical implications

Mass spectrometry approaches to ensure food safety